Report ID: SQMIG35A2903
Report ID:
SQMIG35A2903 |
Region:
Global |
Published Date: November, 2024
Pages:
200
|
Tables:
65 |
Figures:
70
Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to well-developed healthcare infrastructure, especially in Canada and the United States that have easy access to technologically improved medical technologies like RFA devices. The regional growth is also impacted by growing cases of chronic diseases that demand efficient and safe radiofrequency ablation treatments and heavy investments in innovation and research and development. Also, favorable reimbursement policies and high healthcare spending is contributing to the adoption of improved medical devices like RFA devices. The prominent players operating in North America include AngioDynamics, Boston Scientific Corporation, Ethicon Inc., Medtronic, Philips, and more.
Asia-Pacific is the fastest-growing region among others due to growing healthcare infrastructure in key nations like India, China, and Japan. Growing investments in healthcare technology and speedy development are economies that drive the adoption and availability of RFA devices. Moreover, the rising cases of chronic illnesses like cardiovascular and cancer are propelling the demand for RFA treatments. The growing patient population is also offering a major boost for RFA devices, thus the market growth in the region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2903